List of bibliographic references indexed by Plasmid
Number of relevant bibliographic references: 37.
[0-20] [
0 - 20][
0 - 37][
20-36][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000C14 (2012) |
V. S Eputiene [Lituanie] ; A. Bogdaite [Lituanie] ; M. Ruz Auskas [Lituanie] ; E. Suz Iede Liene [Lituanie] | Antibiotic resistance genes and virulence factors in Enterococcus faecium and Enterococcus faecalis from diseased farm animals: pigs, cattle and poultry |
| 000D92 (2009) |
| Short Communication |
| 001092 (2003) |
| Research Abstract Program of the 21st Annual ACVIM Forum Charlotte, NC, June 4–7, 2003 |
| 001093 (2003) |
Jianzhong Wang [République populaire de Chine] ; Xiangmei Chen [République populaire de Chine] ; Hanyu Zhu [République populaire de Chine] ; Lixia Peng [République populaire de Chine] ; Quan Hong [République populaire de Chine] | Relationship Between Aging and Renal High-Affinity Sodium-Dependent Dicarboxylate Cotransporter-3 Expression Characterized With Antifusion Protein Antibody |
| 001154 (2000) |
Mohit K. Baxi [Canada] ; Dirk Deregt [Canada] ; Jill Robertson [Canada] ; Lorne A. Babiuk [Canada] ; Tobias Schlapp [Allemagne] ; Suresh K. Tikoo [Canada] | Recombinant Bovine Adenovirus Type 3 Expressing Bovine Viral Diarrhea Virus Glycoprotein E2 Induces an Immune Response in Cotton Rats |
| 001155 (2000) |
P. Seshidhar Reddy [Canada] ; Neeraja Idamakanti [Canada] ; Lexander N. Zakhartchouk [Canada] ; Lorne A. Babiuk [Canada] ; Majid Mehtali [France] ; Suresh K. Tikoo [Canada] | Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3 |
| 001181 (1999) |
Takayuki Murata [Japon] ; Yasuhiro Takashima [Japon] ; Xuen Xuan [Japon] ; Haruki Otsuka [Japon] | Growth behavior of bovine herpesvirus-1 in permissive and semi-permissive cells |
| 001279 (1995) |
Wenwu Gao [États-Unis] ; Hieronim Jakubowski [États-Unis] ; Emanuel Goldman [États-Unis] | Evidence that Uncharged tRNA Can Inhibit a Programmed Translational Frameshift in Escherichia coli |
| 001317 (1993) |
| Vaccine containing cattle papilloma virus-2 and/or cattle papilloma virus-4 L2 protein; for use as recombinant vaccine or in tumour therapy |
| 001321 (1993) |
| Retrovirus-mediated recombinant fusion protein preparation; vector with Rous-sarcoma virus gag gene myristylation site for recombinant vaccine production in CV-1, COS-1, NIH3T3 or turkey embryo fibroblast cell culture as membranous particle |
| 001323 (1993) |
| Peptides corresponding to regions of HPV-16 E1 and E2 proteins: human recombinant papilloma virus-16 E1 and E2 protein sero-reactive region and monoclonal antibody useful in cervix carcinoma vaccine, diagnosis |
| 001326 (1993) |
| New nucleic acid encoding E2 protein of canine corona virus; dog corona virus recombinant E2 protein production; may be used in recombinant vaccine production |
| 001327 (1993) |
| Induction of immunological response to mammal pathogen; rabies virus, cattle leukaemia virus, cat leukaemia virus or herpes simplex virus antigen gene cloning in an avipox virus vector for use as a recombinant vaccine |
| 001364 (1992) |
| Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
| 001368 (1992) |
Murielle Godet [France] ; Rene L'Haridon [France] ; Jean-Francois Vautherot [France] ; Hubert Laude [France] | TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions |
| 001370 (1992) |
| Recombinant pox virus containing Morbilli virus DNA; expression of e.g. measles virus haemagglutinin glycoprotein in host for construction of a potential recombinant vaccine against dog distemper virus |
| 001378 (1992) |
| Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast |
| 001419 (1991) |
Dieter Moosmayer [Royaume-Uni] ; Heide Reil [Royaume-Uni] ; Martina Ausmeier [Royaume-Uni] ; Jens-Gerd Scharf [Royaume-Uni] ; Hansjorg Hauser [Royaume-Uni] ; Klaus Dieter Jentsch [Royaume-Uni] ; Gerhard Hunsmann [Royaume-Uni] | Expression and frameshifting but extremely inefficient proteolytic processing of the HIV-1 gag and pol gene products in stably transfected rodent cell lines |
| 001452 (1990) |
| Patent reports |
| 001477 (1989) |
| Synthetic peptide antigen corresponding to the major sites of T-lymphocyte recognition within the HIV virus envelope protein: recombinant vaccine production |
| 001478 (1989) |
| Peptide capable of binding rubella immunoglobulin useful for rubella diagnosis and vaccine production; expression in Escherichia coli |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Plasmid"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i \
-Sk "Plasmid" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Teeft.i
|clé= Plasmid
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021 |  |
